Kalpana Kriti, Rao Chandrika, Semrau Stefan, Zhang Bin, Noggle Scott, Fossati Valentina
The New York Stem Cell Foundation Research Institute, New York, NY, USA.
Department of Genetics & Genomic Sciences, Department of Pharmacological Sciences, Department of Artificial Intelligence and Human Health, Mount Sinai Center for Transformative Disease Modeling, Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Methods Mol Biol. 2024 Jul 9. doi: 10.1007/7651_2024_554.
The emergence of brain organoids has revolutionized our understanding of neurodevelopment and neurological diseases by providing an in vitro model system that recapitulates key aspects of human brain development. However, conventional organoid protocols often overlook the role of microglia, the resident immune cells of the central nervous system. Microglia dysfunction is implicated in various neurological disorders, highlighting the need for their inclusion in organoid models. Here, we present a novel method for generating neuroimmune assembloids using human-induced pluripotent stem cell (iPSC)-derived cortical organoids and microglia. Building upon our previous work generating myelinating cortical organoids, we extend our methodology to include the integration of microglia, ensuring their long-term survival and maturation within the organoids. We describe two integration methods: one involving direct addition of microglia progenitors to the organoids and an alternative approach where microglia and dissociated neuronal progenitors are aggregated together in a defined ratio. To facilitate downstream analysis, we also describe a dissociation protocol for single-cell RNA sequencing (scRNA-seq) and provide guidance on fixation, cryosectioning, and immunostaining of assembloid structures. Overall, our protocol provides a comprehensive framework for generating neuroimmune assembloids, offering researchers a valuable tool for studying the interactions between neural cell types and immune cells in the context of neurological diseases.
脑类器官的出现彻底改变了我们对神经发育和神经系统疾病的理解,它提供了一个体外模型系统,概括了人类大脑发育的关键方面。然而,传统的类器官培养方案常常忽视了小胶质细胞的作用,小胶质细胞是中枢神经系统的常驻免疫细胞。小胶质细胞功能障碍与多种神经系统疾病有关,这凸显了在类器官模型中纳入它们的必要性。在这里,我们提出了一种使用人诱导多能干细胞(iPSC)衍生的皮质类器官和小胶质细胞生成神经免疫组装体的新方法。基于我们之前生成有髓鞘皮质类器官的工作,我们扩展了方法,将小胶质细胞的整合包括在内,确保它们在类器官内长期存活和成熟。我们描述了两种整合方法:一种是将小胶质细胞祖细胞直接添加到类器官中,另一种替代方法是将小胶质细胞和分离的神经元祖细胞按确定比例聚集在一起。为便于下游分析,我们还描述了用于单细胞RNA测序(scRNA-seq)的解离方案,并提供了关于组装体结构固定、冷冻切片和免疫染色的指导。总体而言,我们的方案为生成神经免疫组装体提供了一个全面的框架,为研究人员提供了一个宝贵的工具,用于在神经系统疾病背景下研究神经细胞类型与免疫细胞之间的相互作用。